- Release Date: 27/04/23 16:16
- Summary: Enrolment in Ph2b ATTUNE Clinical Trial of BNC210 completed
- Price Sensitive: No
- Download Document 308.91KB
- Forums
- ASX - By Stock
- BNO
- Ann: Enrolment in Ph2b ATTUNE Clinical Trial of BNC210 completed
Ann: Enrolment in Ph2b ATTUNE Clinical Trial of BNC210 completed
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online